Learn More
Invitrogen™ EDC3 Polyclonal Antibody

Description
Recommended positive controls: A431, NIH-3T3, C2C12. Predicted reactivity: Mouse (95%), Xenopus laevis (82%), Chicken (92%), Rhesus Monkey (98%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | EDC3 |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | Edc3 |
| Gene Accession No. | Q8K2D3, Q96F86 |
| Gene Alias | AA517853; EDC3; enhancer of mRNA decapping 3; enhancer of mRNA decapping 3 homolog; enhancer of mRNA decapping 3 homolog (S. cerevisiae); enhancer of mRNA-decapping protein 3; hYjeF_N2; hYjeF_N2-15q23; hypothetical protein FLJ21128; hypothetical protein LOC504054; im:7151288; Lsm16; LSM16 homolog; LSM16 homolog (EDC3, S. cerevisiae); LSM16 protein homolog; MRT50; PP844; RGD1306898; wu:fb82d07; Yjdc; yjeF domain containing; yjeF domain-containing protein 1; YjeF N-terminal domain-containing protein 2; yjeF_N2; YJEFN2; zgc:112006 |
| Gene Symbols | Edc3 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.